GL1X · GenesisL1 explorer

UniProt Q9NQC7

Q9NQC7

Q9NQC7 (UniProt Q9NQC7): 9 experimental structures and 1 predicted model on GenesisL1. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.

UniProt
Q9NQC7
Experimental structures
9
Predicted models
1

Structures

10 records of Q9NQC7 in the MolNFT archive: 9 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
1IXDSolution structure of the CAP-GLY domain from human cylindromatosis tomour-suppressor CYLDsolution nmrA——
1IXDSolution structure of the cap-gly domain from human cylindromatosis tomour-suppressor cyldsolution nmrA——
1WHLSolution structure of the 1st CAP-Gly domain in human cylindromatosis tumor suppressor CYLDsolution nmrA——
1WHLSolution structure of the 1ST cap-gly domain in human cylindromatosis tumor suppressor cyldsolution nmrA——
1WHMSolution structure of the 2nd CAP-Gly domain in human cylindromatosis tumor suppressor CYLDsolution nmrA——
1WHMSolution structure of the 2ND cap-gly domain in human cylindromatosis tumor suppressor cyldsolution nmrA——
2VHFStructure of the CYLD USP domainx-ray diffractionA, B——
2VHFStructure of the cyld usp domainx-ray diffractionA, B——
7OWDStructure of cyld cap-GLY3 (467-552) bound to ub; tetragonal space groupx-ray diffractionB——
Q9NQC7AlphaFold monomer V2.0 prediction for ubiquitin carboxyl-terminal hydrolase cyld (Q9NQC7)predictedA——

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.